Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1991-08-23
1996-12-17
Walsh, Stephen G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 8, 530350, 530395, 930 10, C07K 14705, A61K 3817
Patent
active
055853447
ABSTRACT:
The present invention relates to receptors for advanced glycosylation endproducts derived from rat liver membranes, and that specifically comprise proteins determined to possess molecular masses of about 90 kD and 60 kD, respectively, as assessed by migration during SDS-PAGE. Partial N-terminal sequences have been determined and diagnostic and therapeutic agents, compositions and methods are proposed.
REFERENCES:
patent: 5202424 (1993-04-01), Vlassara et al.
Radoff et al, "Isolation of a Macrophage Receptor . . . " Fed. Proc. 46(6):2116, abstract #1112 (May 1987).
Yang, Z., et al. J. Exp. Med. 174:515-524 published on Aug. 23, 1991.
Vlassara, H. et al. Proc. Natl. Acad. Sci. U.S.A. 82:5588 (1985).
Vlassara, H. et al. J. Exp. Med. 160:197 (1984).
Radoff, S. Diabetes 39:1510 (1990).
Radoff, S., et al. Arch Biochem. Biophys. 263:418 (1988).
Esposito, C. et al. J. Exp. Med. 170:1387 (1989).
Skolnik, E. et al. J. Exp. Med. 174:931-939 (1991).
M. Kirstein et al., Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: Role in vascular disease of diabetes and aging, Proc. Natl. Acad. Sci. USA, 87:9010-9014, Nov. 1990.
Cerami Anthony
Vlassara Helen
Yang Zhi
The Rockefeller University
Walsh Stephen G.
LandOfFree
Liver-derived receptors for advanced glycosylation endproducts a does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Liver-derived receptors for advanced glycosylation endproducts a, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Liver-derived receptors for advanced glycosylation endproducts a will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1991271